Seelos Therapeutics (NXE) Cash flow

2 Followers

Seelos Therapeutics Cash Flow

DE:NXE's free cash flow for Q2 2023 was $-5.90M. For the 2023 fiscal year, DE:NXE's free cash flow was decreased by $-12.61M and operating cash flow was $-5.90M. See a summary of the company’s cash flow.

Cash Flow	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Operating Cash Flow	$ -61.60M	$ -48.99M	$ -20.91M	$ -19.30M	$ -8.13M
Investing Cash Flow	$ ―	$ ―	$ ―	$ ―	$ ―
Financing Cash Flow	$ ―	$ ―	$ ―	$ ―	$ ―
End Cash Position	$ ―	$ ―	$ ―	$ ―	$ ―
Free Cash Flow	$ -61.60M	$ -48.99M	$ -20.91M	$ -19.30M	$ -8.13M